Sofinnova Investments portfolio

Sofinnova Investments (Venture capital) is known to hold 98 companies, 16 of them startups. 14 of them are hiring now, with 1,294 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 3 venture rounds in 12 months, raising $146.5M. Most of them work in Drug Discovery, Oncology Therapeutics, Prescription Drugs.

Source: Alion Venture capital Oct 18, 2026
Investments
98
16 of them startups
Hiring now
14
1,294 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
3
$146.5M raised
Exits
30

Companies Sofinnova Investments has invested in

GSK plc Vaccines Venture round · this month portfolio pageSep 25
Coultreon Biopharma Immunology & Inflammation Therapeutics · Belgium Series A $125M · 5 mo ago lead portfolio page, round in the pressApr 28
NextCure, Inc. Venture round $21.5M · 11 mo ago portfolio pageSep 25
STAR Therapeutics Series D $125M · 12 mo ago portfolio pageSep 25
Avenzo Therapeutics Oncology Therapeutics · United States Series B $60M · 12 mo ago 4 roles portfolio pageSep 25
ArtBio Cancer Care Centers · United States Series B $132M · 14 mo ago lead 2 roles round in the pressJul 29, 2025
RayzeBio Drug Discovery · United States Venture round $370M · 2 yr ago portfolio pageSep 25
BioAge Labs Drug Discovery · United States Venture round $194.4M · 2 yr ago 2 roles portfolio pageSep 25
Alimerasciences Venture round $81M · 3 yr ago portfolio pageSep 25
Merck.com Prescription Drugs · United States Venture round $486 · 5 yr ago 3 roles portfolio pageSep 25
InCarda Therapeutics Hospitals & Health Systems Venture round $28M · 6 yr ago portfolio pageSep 25
Histogenics Venture round $395 · 6 yr ago portfolio pageSep 25
Akouos Venture round $105.1M · 6 yr ago portfolio pageSep 25
Humanigen Venture round $495k · 6 yr ago portfolio pageSep 25
Aeovian Biologics & Biosimilars Venture round $37M · 7 yr ago portfolio pageSep 25
sophirisbio.com Convertible Note $5.1M · 7 yr ago portfolio pageSep 25
Kiniksa Pharmaceuticals Prescription Drugs · United States Venture round $8.8M · 7 yr ago 43 roles portfolio pageSep 25
Ophthotech Venture round $11.4M · 7 yr ago portfolio pageSep 25
Prothena Neurology & CNS Therapeutics Venture round $50M · 8 yr ago portfolio pageSep 25
Alexistogel Venture round $5.5M · 8 yr ago portfolio pageSep 25
aTyr Pharma United States Venture round $45.8M · 9 yr ago portfolio pageSep 25
Roche Prescription Drugs · Switzerland 1034 roles portfolio pageSep 25
Natera Genomics & Genetic Testing · United States 140 roles portfolio pageSep 25
Ascendis Pharma Prescription Drugs · Denmark 27 roles portfolio pageSep 25
Apellis Biologics & Biosimilars · United States 13 roles portfolio pageSep 25
Vera Therapeutics Immunology & Inflammation Therapeutics 8 roles portfolio pageSep 25
Marea Therapeutics Cardiometabolic Therapeutics · United States 6 roles portfolio pageSep 25
City Therapeutics Drug Discovery · United States 4 roles portfolio pageSep 25
Alkeus Pharmaceuticals Prescription Drugs · United States 2 roles portfolio pageSep 25
90Phutzac Sports Media portfolio pageSep 25
Allvue Systems Custody & Fund Administration · United States portfolio pageSep 25
amplyx.com United States portfolio pageSep 25
Anthera Vegan Food portfolio pageSep 25
Capstan Therapeutics Cell & Gene Therapy portfolio pageSep 25
Claris Bio Cell & Gene Therapy portfolio pageSep 25
Dataprediksi2024 LLM & Generative AI portfolio pageSep 25
Genentech Care Coordination & Population Health portfolio pageSep 25
Introducing Keenova and Par Health APIs & Drug Manufacturing · Ireland portfolio pageSep 25
Iterum Therapeutics plc Security Operations portfolio pageSep 25
Karuna Therapeutics (Acquired) Biologics & Biosimilars portfolio pageSep 25
Synlogic Therapeutics Synthetic Biology portfolio pageSep 25
XyloCor Cell & Gene Therapy portfolio pageSep 25

Focus

Markets
Drug Discovery5%
Oncology Therapeutics5%
Prescription Drugs5%
Biologics & Biosimilars5%
Cell & Gene Therapy3%
Immunology & Inflammation Therapeutics3%
Cardiometabolic Therapeutics2%
Rare Disease Therapeutics2%
Where its companies are
United States15%
Belgium1%
China1%
Switzerland1%
Denmark1%
Ireland1%
Stage of its companies
Venture, series not stated81%
Series B10%
Series A5%
Series C and later5%

Questions about Sofinnova Investments

How many companies has Sofinnova Investments invested in?

Sofinnova Investments is known to hold 98 companies: 16 startups, and 30 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Sofinnova Investments investing now?

Yes: in the last 12 months 1 rounds in the press named Sofinnova Investments (1 as the lead), and 0 companies joined its portfolio page in 90 days.

What does Sofinnova Investments invest in?

The markets of the companies Sofinnova Investments holds: Drug Discovery (5%), Oncology Therapeutics (5%), Prescription Drugs (5%), Biologics & Biosimilars (5%), Cell & Gene Therapy (3%).

Which Sofinnova Investments portfolio companies are hiring?

14 companies Sofinnova Investments holds are hiring now, with 1,294 open roles listed on this page.

Who does Sofinnova Investments invest alongside?

The investors that hold the most companies together with Sofinnova Investments: RA Capital Management, NEA, Aisling Capital, Longitude Capital, OrbiMed.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 18; 2 rounds in the press that name it

Sofinnova Investments portfolio: 98 known companies. Alion, Oct 18, 2026. https://alion.io/company/sofinnova-investments/portfolio

Licence: CC BY-SA 4.0JSON